Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cassava Sciences Q3 EPS $(0.61) Beats $(0.77) Estimate

Author: Benzinga Newsdesk | November 07, 2023 10:09am
Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.77) by 20.78 percent. This is a 19.61 percent decrease over losses of $(0.51) per share from the same period last year.

Posted In: SAVA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist